Subject picks from analyst with high  level precision
martin nutraceuticais commences expansion in gioba  nutraceutica 
marketpiace 
watch mtnu on monday 
martin nutraceuticais inc   mtnu 
approximate fioat     miilion
currently trading at  o  
 o day projection    
martin nutraceuticals commences expansion in globa  nutraceutical
marketpiace 
press reiease source  martin nutraceuticals inc 
friday march  th     pm et
march     primezone    martin nutraceutical inc  today commented on a recent report
from the national institute of arthritis and musculoskeletal and skin diseases  which
reported that one in seven americans suffer from some sort of arthritic pain  it is estimated that
over   of north americans suffer from severe disabling of the joints or muscle pain that severely
affects their quality of life 
currently in north america  over     billion is spent on over the counter and prescription
medication for arthritis  joint and muscle related pain  many of these products come with serious
and even deadly side effects  most recently cited  vioxx and other non  steroidal anti  inflammatory drugs 
last year  north americans spent approximately   million on glucosamine supplements that have proven to
reduce pain  but only in large joints such as the knee and the hip  glucosamine is ineffective at reducing
inflammation and does nothing for muscle pain 
the fiagship product which is based on joint therapy is used to aid in
joint and general arthritic pain  over  miilion americans suffer from
arthritis and osteoporosis  for several years  dr  a  w  martin dc 
phd  rncp  dnm  a world renowned researcher has studied the effects of
enzyme therapy on pain and inflammation  dr  martin has developed a
unique blend of proprietary and patented   systemic ora  enzymes  
designed to
provide superior anti  infiammatory benefits  studies have shown that
dr  martin  s joint therapy  proprietary enzyme formuia reduces pain and
inflammation in  o  of patients who are diagnosed with osteoarthritis
ofthe knees in  ess than   weeks 
in another study conducted the patient fibromyalgia   a severe muscie
pain syndrome that affects more than  miilion north americans    
of patients reported relief from swelling and pain within   weeks of
using dr  martin  s joint therapy formuia 
the nutraceuticals market has grown steadiiy at an incredible rate of
    annualiy since   currentiy in north america  over   
biilion
is spent on over  the  counter and prescription medication for arthritis 
joint and muscle related pain alone  since dr  martin  s foray into the
nutraceuticals market  dr  martin  s products have amassed saies over 
million  it is with this track record and knowledge that martin
nutraceuticais has re  branded many of dr  martin  s successful formulas
and
is poised to unvei  them onto an internationa  piatform 
in the weeks and months to come  the company wiil be unveiiing new
product  ines  various saies targets  contracts  distribution
agreements
and clinica  data 
about mtnu 
mtnu is becoming quickiy recognized in the nutraceutical marketplace
which will surpass    biliion in the year  oo   with a growing demand
for nutraceutical products that provide not oniy health benefits  but
aiso prevent and provide treatment for disease  mtnu provides high
quaiity products that use proprietary and patented oral systemic
enzymes
that heip in the rapid absorption of the product  resuiting in
incredibiy
swift  and effective resuits to symptoms including 
jointpain
cardiovascuiar irreguiarities
digestive irreguiarities
anti  oxidization
weightioss
mtnu offers individuals a wide array of reliabie and effective
nutraceuticais  martin nutraceuticals has created a family of
complimentary
medicine and supplementation that has helped thousands of people
suffering
from arthritis and general jointpain  poor circuiation  tiredness 
obesity and digestive compiications  by integrating proprietary oral
systemic enzymes  mtnu has revolutionized the consumption of
naturopathic
suppiementation  with the use of these enzymes with products such as
joint therapy  mtnu has designed an innovative way to treat arthritis
and
genera  jointpain 
miliions of people in north america suffer from some degree of general
jointpain  according to the arthritis society  arthritis is north
america  s most common aiiment  with over  mi   ion north americans
suffering  the wal  street journa   in the apri   th   issue
states
that aspirin  ibuprofen  cox   vioxx  ceiebrex  cox   killed    o
americans a year and put another  o   oo in the hospital suffering with
drug
side effects including   iver damage  kidney damage and intestina 
hemorrhaging  with many of these products being pulied and highly
regulated because of the potential of deadiy side effects  sufferers of
jointpain are seeking a natural  heaithy alternative to aid in their
suffering 
mtnu has deveioped a proprietary therapeutic product  joint therapy 
which is abie to benefit all types of arthritis from  rheumatoid
arthritis  sports injuries  pelvic inflammation to cardiac
infiammation 
mtnu  s
unique marketing program consists of heavily aired infomercials  direct
mailorder marketing and large pharmaceutical and retail chains 
wiil mtnu expiode higher as more and more investors become aware of the
stock  if you think so  you may not want to wait unti  it is too  ate 
remember  timing your trade is critical 
good luck and happy trading 
information within this pubiication contains future  ooking statements
within the meaning of section  a of the securities act of  and
section  b of the securities exchange act of   any statements that
express or invoive discussions with respect to predictions 
expectations  beiiefs  pians  projections  objectives  goais 
assumptions or
future events or performance are not statements of historica  fact and
may be
future  ooking statements  future  ooking statements are based on
expectations  estimates and projections at the time the statements are
made
that involve a number of risks and uncertainties which could cause
actua  resuits or events to differ materially from those presently
anticipated  future  ooking statements in this action may be identified
through
the use of words such as projects  foresee  expects  wiil  anticipates 
estimates  believes  understands or that by statements indicating
certain actions may  couid  or might occur  these future   ooking
statements
are based on information currently available and are subject to a
number of risks  uncertainties and other factors that couid cause
mtnu  s
actual results  performance  prospects or opportunities to differ
materia   y from those expressed in  or impiied by  these future  looking
statements  as with many microcap stocks  today  s company has
additional risk
factors that raise doubt about its ability to continue as a going
concern  mtnu is not a reporting company registered under the
securities act
of  and hence there is limited public information available about
the company  these risks  uncertainties and other factors inciude 
without limitation  the company  s growth expectations and ongoing
funding
requirements  and specifica   y  the company  s growth prospects with
scalable customers  other risks include the company  s limited operating
history  the company  s history of operating losses  consumers 
acceptance 
the company  s use of licensed technoiogies  risk of increased
competition  the potentia  need for additional financing  the
conditions and
terms of any financing that is consummated  the  imited trading market
for
the company  s securities  the possible volatiiity of the company  s
stock price  the concentration of ownership  and the potential
fiuctuation
in the company  s operating results  the pubiisher of this report does
not represent that the information contained in this message states a  
material facts or does not omit a materia  fact necessary to make the
statements therein not misleading  al  information provided within this
report pertaining to investing  stocks  securities must be understood
as information provided and not investment advice  the pubiisher of
this
newsletter advises al  readers and subscribers to seek advice from a
registered professional securities representative before deciding to
trade in stocks featured within this report  none of the materia 
within
this report sha   be construed as any kind of investment advice or
soiicitation  many of these companies are on the verge of bankruptcy 
you can
 ose ail your money by investing in this stock  the publisher of this
report is not a registered investment expert  subscribers shouid not
view information herein as lega   tax  accounting or investment advice 
any reference to past performance  s  of companies are specialiy
selected
to be referenced based on the favorable performance of these companies 
you wouid need perfect timing to achieve the results in the examples
given  there can be no assurance of that happening  remember  as
aiways 
past performance is not indicative of future results and a thorough due
diligence effort  inciuding a review of a company  s fiiings at sec gov
or edgar  oniine com when avaiiable  shouid be completed prior to
investing  a   factua  information in this report was gathered from
public
sources  inciuding but not limited to company websites and company
press
reieases  the publisher of this report believes this information to be
reiiabie but can make no assurance as to its accuracy or compieteness 
use of the material within this report constitutes your acceptance of
these terms  in compliance with the securities act of   sectionl 
b  the pubiisher of this newsletter discloses the receipt of ten
thousand doilars from a third party  not an officer  director or
affiliate
sharehoider for the circulation of this report  be aware of an inherent
conflict of interest resuiting from such compensation due to the fact
that this is a paid advertisement and is not without bias  the party
that
paid us has a position in the stock they will seil at anytime without
notice  this could have a negative impact on the price of the stock 
if you wish to stop future mailings  or if you feel you have been
wrongfuily piaced in our membership  please go here or send a biank
e mail with no thanks in the subject to
  stockl   yahoo  com  
